PortfoliosLab logo

Achilles Therapeutics plc (ACHL)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS00449L1026
CUSIP00449L102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.54
Year Range$1.96 - $9.93
EMA (50)$2.54
EMA (200)$4.40
Average Volume$61.76K
Market Capitalization$103.56M

ACHLShare Price Chart


Chart placeholderClick Calculate to get results

ACHLPerformance

The chart shows the growth of $10,000 invested in Achilles Therapeutics plc on Apr 1, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,535 for a total return of roughly -84.65%. All prices are adjusted for splits and dividends.


ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-0.78%-6.21%
YTD-49.30%-18.17%
6M-54.40%-17.47%
1Y-76.76%-8.89%
5Y-77.99%-1.48%
10Y-77.99%-1.48%

ACHLMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

ACHLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Achilles Therapeutics plc Sharpe ratio is -1.04. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLDividend History


Achilles Therapeutics plc doesn't pay dividends

ACHLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

ACHLWorst Drawdowns

The table below shows the maximum drawdowns of the Achilles Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Achilles Therapeutics plc is 89.03%, recorded on May 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-89.03%Apr 7, 2021276May 9, 2022
-9.85%Apr 1, 20212Apr 5, 20211Apr 6, 20213

ACHLVolatility Chart

Current Achilles Therapeutics plc volatility is 33.38%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


ACHL (Achilles Therapeutics plc)
Benchmark (^GSPC)

Portfolios with Achilles Therapeutics plc


Loading data...